Lv63
2660 积分 2023-08-15 加入
Ovarian Carcinomas
17小时前
待确认
Real-world outcomes after Mirvetuximab Soravtansine treatment for recurrent ovarian Cancer: Results from a university setting
19小时前
求助中
From histological and molecular pathology to the inclusion of antibody-drug conjugates in clinical practice against ovarian cancers: Mechanisms of action and pharmacological safety
19小时前
待确认
Alkaline phosphatase fluorescent probes: Design strategies, bioimaging applications, and future perspectives
1天前
待确认
Genetic, structural, and functional foundations of alkaline phosphatase measurement in clinical diagnostics
1天前
待确认
Interpreting alkaline phosphatase in clinical practice: integrating analytical advances and physiological context
1天前
求助中
[52Mn]Mn-BPPA-Trastuzumab: A Promising HER2-Specific PET Radiotracer
1天前
待确认
Evaluation of 9-Minute Dual-Energy Peak Time–Reduced 360° CZT Total-Body [ 177 Lu]Lu-PSMA SPECT/CT Imaging with Comparisons to [ 68 Ga]Ga-PSMA PET
4天前
已关闭
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
6天前
已完结
Prognostic Value of Posttherapy SPECT/CT for Overall Survival in Patients Undergoing [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy: Results from 3 Clinical Trials
6天前
已完结
皖公网安备34019202002308
